Director, National Thought Leader Liaison

Nuvalent, Inc.(4 days ago)

HybridFull TimeDirector$216,000 - $252,000Commercial

About this role

The Director, Thought Leader Liaison at Nuvalent will lead engagement with lung cancer thought leaders and external influencers as the company prepares for the launches of Zidesamtinib and Neladalkib. This role partners closely with Commercial and Marketing teams to ensure alignment with brand objectives and launch readiness while serving as a key internal coordinator for thought leader relationships.

View Original Listing

Required Skills

KOL Engagement
Stakeholder Management
Commercial Strategy
Insights Integration
Cross-Functional Collaboration
Multichannel Marketing
Speaker Identification
Compliance Management
Data Analysis
Project Management

+2 more

Qualifications

Bachelor’s Degree
Advanced Degree (Preferred)

About Nuvalent, Inc.

nuvalent.com

Nuvalent is a clinical‑stage, Cambridge‑based oncology company that designs precisely targeted small‑molecule therapies using deep chemistry know‑how and structure‑based drug discovery. Its pipeline focuses on selective kinase inhibitors aimed at genetically defined cancers (ALK, ROS1, HER2 and other kinase-driven solid tumors) with the goal of overcoming resistance and improving patient outcomes. Lead programs include NVL‑520, NVL‑655 and NVL‑330, and the company highlights an approach centered on precision medicine, structure‑guided design, and translational development.